JYLAMVO
Methotrexate
- Strength
- 2 mg/mL
- Form
- Solution
- Class
- Folate Analog Metabolic Inhibitor
SHORLA ONCOLOGY INC.
Listed by Proficient Rx LP
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Folate Analog Metabolic Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 82804-136 |
| FDA application | ANDA213343 |
| RxNorm concept | 105585 |
| Package sizes listed | 1 |
| Marketed since | August 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Methotrexate
SHORLA ONCOLOGY INC.
Accord Healthcare, Inc.
Eugia US LLC
Hospira, Inc.
Alembic Pharmaceuticals Inc.
Zydus Lifesciences Limited
Bryant Ranch Prepack
Teva Parenteral Medicines, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.